Crossmark

Ceftazidime-avibactam combination therapy versus monotherapy for treating carbapenem-resistant gram-negative infection: a systemic review and meta-analysis

Crossref DOI link: https://doi.org/10.1007/s15010-024-02277-y

Published Online: 2024-05-13

Published Print: 2024-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Hsu, Wei

Chuang, Min-Hsiang

Tsai, Wen-Wen

Lai, Chih-Cheng

Lai, Hsin-Yu

Tang, Hung-Jen
License Information

Text and Data Mining valid from 2024-05-13

Version of Record valid from 2024-05-13
More Information

Article History

Received: 27 February 2024

Accepted: 18 April 2024

First Online: 13 May 2024

Declarations

:

: All authors declare that there was no conflict of interest.

Document is current

Any future updates will be listed below